Test
Embed Size (px)
DESCRIPTION
test
Citation preview
-
!""#!$%&'%(
!"
#" $%$$$%&$$%&$$$%$''
) *+
()"*
* + "*
( )% % ,
-./0")
, &!""#!$-
(+*12
-./
"2 * 1
(*1*-./
(-./3
( -./ "
. &%/-0*-
456"
"7
56
8!9
-./
6"-./
666202!9
1 '
(&2
#: ! " -1 &") ;
3 #&4%5 '
&%26
75!"8596:5:5%%
8(9 86 8< 8# 8!9
; !%4
(* ! - # 8*=0
8
=? .
)"*1 .
, 8@+%*
+
-
) ? 69'%-
:%5
9&2(%208
= C, 6 =
, =.+5 96 4 ( - :% % %
:%'>8'2
" " "0" *" "
. =+5 %&88%&%%
!-./ 6! 6 (
=.+519:5* 6'%#&2
2 0
.%2
C" #, 8
?)35)%50:%& 9&0(%&082
.+ ="%1
+2
="%1
+2
%,
$ 5%,
) !&
0%
0"
F0% ()+@ F)
, !2
. $ F048800 F*
. = ), +5 2 0 % '98'()%2
-
0$'9&:%96(59&&'@(%&''6!2%
= 6 = ! . 0+
1 ? 8 9 A 5 :%2 '65 (%!2'%
! = !, = . 0+
3 !%
6+ 6% /%"%+ /%%+ 6
; =+55 )%#:%9%.0&26%
9&:(!
;
6 .+ &, &,
-
)3 =;+5 A)3%5$-;4I4B59* A&9
59%@5 %!2
- 8 ! 5""
); =)+5 .%(K*
-
. #'&(5@#*
6 6, 6 -! ;@1
. &
; * !* #"% % 0
( =*
.) 0A%&6
#+/=-B , 1) C" &).
., *+/-0*-
(,@* ("* (,* 6"* +
.. "&=5+/-0*-
.C($6 ((#8 !$D+($6 8 ;+"@
.1 !99
%&&8
??? (
-, !
, ," -
"
0
.3 #5 8%!""#!$-
.% #% #%*
%
%
.; >8/-0*
(+ +0 D"02
F (1)
.
-
8
-
!"# "$% &!
'
!
"# ( ( !
)#!
) *
!
"# #
+
!
)
'&
!"#
!,!
' -./!0001
+ -/2!0001!3
4 !
$(55556556555577
(!,
!
(*!
)
!8+*!9
!3
!
"$%
*(!"*
$%-:; 1!' 2;!'
(!9 *(
(
-
!"
#
$
%#
&%
'(
&
%
)
*
+
+
,
*
&
-(
*
+.
+
/
%
&
-(
&.
0
+
/
)(:/
- B1!C
D!"#
E/!"(
!
!!"
#$
#
%!
)*
E:24(
-((1!
"
*!"
!
9
:(!)
!"
$)-1!)(
/0 ! ) +
!)
8F,)>(
!9 *($5
+ & :!G
$5-1 &!
!
"
#
$
%
%
#
&
'
$
%(
&
)'
*!
&)
&!
-
"#
& >(!G./0.=0!)
-E.=01&
-H./01!)
* !9 !
G >$>!8&-.0/21&-2.01-E/21-H21!"+!
9
!'!8(#!
" (
(85,' !'( *!
# I/2 I40 aos
Histerectoma totalcon mola in situ
Legrado poraspiracin
La enfermedadregresa
Si el nivel de BHCG nodesciende o permaneceelevado a las 8
semanas
Es una enfermedadtrofoblsticapersistente
Si tiene foco
extrauterino
Es una enf.trofoblsticametastsica
Quimioterapia (metotrexate)y al 3 daer
Legrado Histerectoma
Si datos de mal pronstico:- HCG>400.000 mU/ml- t>4 meses
desde la
ltima gestacin- Metstasis cerebro/hgado- Fracaso de QT previa-
Embarazo a trmino previo
No
Poliquimioterapia QT(MTX)
"
$%M
+#
!"
# ##@9$!
"
*!N !$#
!) $%E
-
4*
!)# &
!"*(
!
, (
(!,
"#
! $
# (!
8 #&D+ (!' (
$%!" &!'+
(!
)
(
P *
!"(!
8 G
!'
*!
@*#.14
* (!"
!)
(!) ( (!"#
(*
!@* ($5!"**
!
)+
#*!"
!) F!
)>' !
'
>'!>'
*P !
)) !'
P -1!)) ( !
Temperatura corporal basal
LH
FSH
Progesterona
Estradiol
Dia 5 Dia 14 Dia 21 Dia 28 Dia 5
37o
36o
0
100
200
0
0
0
25
50
75
4
8
8
12
16
16
Liberacin unimodal
Liberacin bimodal
1
4
3
2
1. Por efecto feed-back positivo de los estrgenos
2. Crece cohorte folicular
3. Seleccin del folculo dominante
4. Estmulo del crecimiento de la granulosa y la
actividad aromatasa
"
)
! ' + # !) , ! &! 9
! 8
!
*(
'! 9
!
'!PPOT#+!"-
-
$%
&%
"85C
!
) "
! 5* ! '
! '
!
@ ! 9! 5!
) *
&85C!
)
-85C14*!@*
!) &
85C!)
* -"5,1
85C( 85C
!
$
% (
(
$! $!
!9(!
@
!
@ # @9#!":=!
"
555655577
555!
, ( )8)
8)
*!
G& !9 ! 9
>+!
) (:2 4
*
(
*!)
+
>'
-+(1!$(
*
*!
"(
!"
->')1!"
&
*!
)
(&204&204
4!
8
" &
(* &(-8))8)1!' $! &-
2I41!
@**
'3$ - (*
-
1 -1*'3$-#1!
#
*-'"O1
(
!' (* # (!
>
!)
&($!&(!3#
* #!
"#(
"
&
($!
@ *(O("8!
G
*
",G$!'
-
1 &
-1
*
(!
)
JK!
)
+!)(
#(!
"*
(!" 9%:=
-1!
8
!
%
!
9 !
3
(
( (!)&&
-1
-1!, &(!)
!
)
#(
!
)
4&! )
*!
)
*
!)(
"
#!
8 *&+4#"@'!
"
& -.2:S41! $&!
) "5,
*!
) (
*
-"5,1!"((
!"!9
"5,
%
&'
! 8 #! 8# #!
#+! "( (!
>:M$! ).0!200! 6'%
! %#
#5>8!
( *!)
## (
!
) (
!
)
!9 !)
!$(
!
'+#((
D
-1!"*(!
)
(
!
-
%
(
)
!"
#"
$%&
'"
"
-
, "(
(
( ) ! 9#! ,
! ,! 3 !
@9$O*+# !
O
$./2$"9$%!
"
+!'* 5
! 55
-+1! 555
! 56!
@*
# 9. ! F/ ! $./
!
" +
*
!
5(#(
(* (( + & !
"(++
(
&
& *
* !
(
!9*
$
9,! $ (
!'(
!
$ - 1
*!
'(&)
)
!, * #!
$53555(!' V !
$53555!
* #
,
#&! 5,6-.=.M1! 5! @! 8 !
)
+()
9&
(
!"
!
)-
1 & - 1! )
-*1
! '
(#(!
5++! 9! F20L! $20L!
55* #! 9 ! F !
555 ! 56!
